Evidence backs surgery for BRCA1/2 women:
This article was originally published in Clinica
Women with mutations in their BRCA1 and BRCA2 genes may be three times less likely to develop breast or ovarian cancer if they undergo surgery. In a prospective study of 170 patients, researchers found that the removal of the ovaries and fallopian tubes, or oophorectomy, was associated with a 75% decreased risk of subsequent breast or ovarian cancer. The study, by researchers from the Memorial Sloan-Kettering Cancer Center, in New York, appears in The New England Journal of Medicine (May 23).
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.